BioNexus Gene Lab
BGLC
#11194
Rank
C$2.86 M
Marketcap
C$0.98
Share price
0.00%
Change (1 day)
-84.49%
Change (1 year)

EPS for BioNexus Gene Lab (BGLC)

EPS in 2026 (TTM): C-$1.50

According to BioNexus Gene Lab's latest financial reports the company's current EPS (TTM) is C-$1.55. In 2025 the company made an earnings per share (EPS) of C-$2.30 a decrease over its 2024 EPS that were of C-$1.29.

EPS history for BioNexus Gene Lab from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$1.50-35.04%
2025C-$2.3079.15%
2024C-$1.29-45.96%
2023C-$2.38260.87%
2022C-$0.66-195.83%
2021C$0.69-66.67%
2020C$2.06-600.17%
2019C-$0.41-1031.69%
2018C$0.04431

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
C-$1.94 24.88%๐Ÿ‡บ๐Ÿ‡ธ USA